< Home < Back

Rubra Medicaments - Quaterly Results

Date: 29-01-2026
The total revenue surged to Rs. 1740.87 millions, up 173987.00% for the December 2025 quarter as against Rs. 1.00 millions during the year-ago period.The Total Profit for the quarter ended December 2025 of Rs. 5.76 millions grew from Rs.-0.18 millions Operating profit Margin for the quarter ended December 2025 improved to 7.70% as compared to -0.37% of corresponding quarter ended December 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 1740.87 1.00 173987.00 2943.94 2.50 117657.60 5.00 11.30 -55.75
Other Income 0.00 0.01 0.00 0.00 0.01 0.00 0.00 0.00 0.00
PBIDT 7.70 -0.37 -2181.08 26.56 -0.38 -7089.47 0.56 0.29 93.10
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00
PBDT 7.70 -0.16 -4912.50 26.56 -0.17 -15723.53 0.55 0.29 89.66
Depreciation 0.01 0.02 -50.00 0.01 0.06 -83.33 0.08 0.07 14.29
PBT 7.69 -0.18 -4372.22 26.55 -0.23 -11643.48 0.47 0.22 113.64
TAX 1.93 0.00 0.00 6.67 0.15 4346.67 0.22 -0.08 -375.00
Deferred Tax -0.03 0.00 0.00 -0.03 0.15 -120.00 0.07 -0.08 -187.50
PAT 5.76 -0.18 -3300.00 19.88 -0.38 -5331.58 0.25 0.30 -16.67
Equity 54.68 54.68 0.00 54.68 54.68 0.00 54.68 54.68 0.00
PBIDTM(%) 0.44 -37.00 -101.20 0.90 -15.20 -105.94 11.20 2.57 336.41